References 1. Meyer zum Buschenfelde C, Hermann C, Schmidt B, Peschel C, Bernhard H: Anti -HER2 monoclonal antibody trastuzumab enhances cytolytic activity of class I restricted HER2 -specific T lymphocytes against HER2 -overexpressing tumor cells. Cancer Research 62:2244- 2247, 2002 2.